2021 Recipients
Valerie Chew, PhD
Translational Immunology Institute (TII), SingHealth-DukeNUS
Singapore
“Discovery of biomarkers and novel therapeutic strategies for immunotherapy in Hepatocellular carcinoma”
Sadahisa Ogasawara, MD, PhD
Department of Gastroenterology, Graduate School of Medicine Chiba University
Chiba, Japan
“Understandings the mechanism of energy metabolization in intratumor immune microenvironment in metabolic related hepatocellular carcinoma”
Yotaro Kudo, MD, PhD
The Dept. of Gastroenterology, The Graduate School of Medicine, The University of Tokyo
Tokyo, Japan
“The Novel Role of Atypical Protein Kinases C as Key Regulators for Biliary Development, Regeneration, and Tumorigenesis”
2020 Recipients
Hyuk Soo Eun, MD, PhD
Chungham National University Hospital
Daejeon, South Korea
"The major role of NADPH Oxidase 2 – mTORC1 axis in nonalcoholic fatty liver disease-associated hepatocellular carcinoma "
Yuichi Hara, MD
Kawasaki Medical School
Okayama, Japan
"Elucidation of the mechanism underlying iron loss-induced mitophagy and its role in suppression of hepatocellular carcinoma in nonalcoholic steatohepatitis"
Nai Yang Fu, PhD
Duke-NUS Medical School
Singapore
"Exploring the potential of TSPAN8 as a novel biomarker and therapeutic target of hepatocellular carcinoma"
Jung Chen Su, PhD
National Yang Ming University
Taipei, Taiwan
"Identification of Transcription Factor Targets Regulating Multi-Kinases and Acquired Resistance Genes for Drug Development in Hepatocellular Carcinoma”
2019 Recipients
Yun Shen Chan, PhD
Genome Institute of Singapore
Singapore, Singapore
"Unraveling The Molecular Response of NASH Treatment Drugs Using an in Vitro Human Adult Stem Cell Derived Liver Organoid Model"
Hyon- Seung Yi, MD, PhD
Chungnam National University
Daejeon, South Korea
"The Role of Activating Transcription Factor 5-Mediated Mitochondrial Unfolded Protein Response in Fatty Liver Disease"
Thuy Thi Thanh Le, MD, PhD
Osaka City University
Osaka, Japan
"Exploration The Novel Role of Cytoglobin As Therapeutic Approach For Liver Fibrosis And Cancer"
Yuchen Xia, PhD
Wuhan University
Hubei, China
"Dissecting Hepatitis B Virus Covalently Closed Circular DNA"
2018 Recipients
Li-Rung Huang, PhD
National Health Research Institutes
Miaoli County, Taiwan
Development of T-cell Immunotherapy Able to Resist T-cell Exhaustion for Treatment of Hepatocellular Carcinoma
Ruqi Tang, PhD
Shanghai Jiao Tong University
Shanghai, China
Interplay of Host Genetics and Gut Microbiota in Primary Biliary Cholangitis
2018 Recipients (Research Scholars Program in Liver Disease Japan)
Eisuke Murakami, MD, PhD
Hiroshima University Hospital
Hiroshima, Japan
Analysis of molecular mechanisms involved in development of non-alcoholic steatohepatitis
Kazuya Okushin, MD, PhD
The University of Tokyo
Tokyo, Japan
Investigation of a novel mechanism of NASH pathogenesis focused on bile acid transporters, and exploration of a new therapeutic strategy
2017 Recipients
Hye Won Lee, MD, PhD
Yonsei University College of Medicine
Seoul, South Korea
Cell-Free Circulating Tumor DNA as a New Possible Predictive Biomarker in Hepatocellular Carcinoma Development in Asian Patients with Chronic Liver Disease
Sheng-Han Wang, PhD
National Taiwan University College of Medicine
Taipei, Taiwan
Hepatocel/ular Carcinoma in HBV/HCV Dual Infection Patients: How Many are Contributed or Primed by HBV Infection as Revealed by Tumor Integrated HBV DNA Analysis?
2017 Recipients (Research Scholars Program in Liver Disease Japan)
Takahiro Kodama, MD, PhD
Osaka University
Osaka, Japan
Understanding of the novel regulatory mechanism of de-differenciation-mediated hepatocellular carcinoma progression via non-canonical NF-kB and PI3K pathways.
Sayuri Nitta, MD, PhD
Tokyo Medical and Dental University
Tokyo, Japan
Elucidation of the pathophysiological mechanism of HBV in persistent infection and tumorgenesis
2016 Recipients
Young-Sun Lee, MD, PhD
Korea University College of Medicine
Seoul, Korea
Investigating the Roles of CX3CR1 Related with Functional Polarization of Tissue-Resident Macrophages in Alcoholic Liver Disease
Chuanlong Zhu, MD, PhD
The First Affiliated Hospital of Nanjing Medical University
Nanjing, China
Develop Novel Anti-HBV Strategies Based on the Role of EFTUD2 in Innate Immunity